We are delighted to share that C2i’s Lead Scientist Michael Chan has been promoted to Professor by the School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong.
Professor Michael Chan joined HKUMed’s School of Public Health as a post-doctoral fellow in infectious diseases in 2004 after receiving his PhD in Medical Science from The Chinese University of Hong Kong. He is a world expert on understanding the pathogenesis of influenza viruses and coronaviruses.
“Louis Pasteur’s dictum, “the microbe is nothing, the terrain is everything” rings true for Professor Chan, who has made his career studying the terrain for infections by developing human organoids of lung tissue into platforms for risk assessment, and exploring therapeutic options for acute lung injury.
His scientific contributions have had a major impact, ranking him among the “top 1% most-cited international scientists” and propelling his papers into top journals. But what truly stands out is his unwavering commitment to making a difference here in Hong Kong. From spearheading impactful initiatives like the “Little Dr Flu” programme to advising global organizations, Professor Chan’s work has touched countless lives and will continue to shape the future of public health.”
Professor David Bishai, Director, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong.
Professor Chan has spearheaded significant translational projects in infectious and respiratory diseases, resulting in the establishment of C2iTech, C2i’s first spin-off company, and earning international recognition, including multiple Gold medals from the prestigious International Exhibition of Inventions in Geneva.
Comments